(talazoparib)
TALZENNA is supplied in strengths and package configurations as described in Table 12:
Package Configuration | Capsule Strength (mg) | NDC | |
Bottles of 30 capsules | 0.1 | 0069-0252-30 | Red oval liquid-filled soft gelatin capsule printed with “TLZ” and “010”. |
Bottles of 30 capsules | 0.25 | 0069-0353-30 | Yellow oblong liquid-filled soft gelatin capsule printed with “TLZ” and “025”. |
Bottles of 30 capsules | 0.35 | 0069-0454-30 | Pink oblong liquid-filled soft gelatin capsule printed with “TLZ” and “035”. |
Bottles of 30 capsules | 0.5 | 0069-0546-30 | Pale orange oblong liquid-filled soft gelatin capsule printed with “TLZ” and “050”. |
Bottles of 30 capsules | 0.75 | 0069-0655-30 | Red oblong liquid-filled soft gelatin capsule printed with “TLZ” and “075”. |
Bottles of 30 capsules | 1 | 0069-0757-30 | Reddish brown oblong liquid-filled soft gelatin capsule printed with “TLZ” and “1”. |
{{section_name_patient}}
{{section_body_html_patient}}
Additional Resources
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.
Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.
Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for a Pfizer medicine or a vaccine.
The submission will be reviewed during our standard business hours.
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.